Drug Patent Watch

DECEMBER 18, 2024

Drug patent prosecution is a complex and critical process that can make or break the success of a new medication. As a business professional in the pharmaceutical industry, understanding and implementing effective strategies for drug patent prosecution can be the difference between market domination and missed opportunities.

Pharmaceuticals 93

Pharmaceuticals Drugs Drug Development Pharmaceutical Companies 93

Drug Target Review

DECEMBER 20, 2024

Artificial intelligence (AI) has revolutionised many industries, yet its adoption in pharmaceutical drug development has been notably slower. For years, AI and machine learning (ML) were often dismissed as little more than advanced statistics with little practical value in drug development.

Clinical Trials 128

Clinical Trials Trials Pharmaceuticals Drug Development 128

BioPharma Drive: Drug Pricing

NOVEMBER 13, 2023

How can these increase the probability of success or efficiency in a pre-clinical and clinical drug development program? Regulatory agencies have set the framework and use cases for RWE.

Drug Development 269

Drug Development Pharmaceuticals Drugs 269

Drugs.com

MARCH 25, 2025

TUESDAY, March 25, 2025 -- Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity and diabetes drug, the company announced March 24. The drug, called UBT251, is being developed.

Pharmaceutical Companies 263

Pharmaceutical Companies Drugs Pharmaceuticals 263

Drug Patent Watch

MAY 19, 2025

"Revolutionizing the Pharmaceutical Industry: How AI-Powered Portfolio Management is Changing the Game As the pharmaceutical landscape continues to evolve, companies are under increasing pressure to optimize their portfolios and stay ahead of the competition. link] #pharmaceuticals #portfoliooptimization #AIinpharma"

Pharmaceuticals 80

Pharmaceuticals Pharmaceutical Companies Marketing Drugs 80

Drugs.com

APRIL 4, 2024

THURSDAY, April 4, 2024 (HealthDayNews) -- Following disappointing trial results, the maker of a controversial ALS drug said it is pulling the medication off the market. In a statement issued Thursday, Amylyx Pharmaceuticals said that Relyvrio.

Marketing 279

Marketing Drugs Pharmaceuticals Trials 279

Drugs.com

MARCH 11, 2024

MONDAY, March 11, 2024 -- Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. In a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a.

Marketing 289

Marketing Trials Drugs Pharmaceuticals 289

Drug Patent Watch

DECEMBER 10, 2024

India has long been recognized as a significant player in the global pharmaceutical industry, particularly in the production of generic drugs. The country’s pharmaceutical sector has experienced substantial growth over the years, driven by both domestic and international demand for affordable and high-quality medicines.

Government 90

Government Drugs Pharmacy Pharmaceuticals 90

BioPharma Drive: Drug Pricing

SEPTEMBER 20, 2023

Targeted protein degradation has emerged as one of the more competitive areas of pharmaceutical research in recent years as scientists develop new ways to reach difficult-to-drug targets.

Targeted Protein Degradation 268

Targeted Protein Degradation Drugs Pharmaceuticals Research 268

Drug Patent Watch

MAY 27, 2025

"Unlock Hidden Profits in Pharmaceutical R&D: A recent analysis of top-selling medications reveals that companies that closely monitor their competitors' patent portfolios are 3x more likely to achieve a higher return on investment in drug development. link] #pharmaceuticalinnovation #drugdevelopment #patentportfolio"

Drug Development 93

Drug Development Drugs Pharmaceuticals 93

Drug Patent Watch

DECEMBER 9, 2024

In the vast realm of pharmaceutical research and development, there’s a fascinating intersection between ancient wisdom and modern science. This intersection is where pharmacognosy meets drug patents, creating a unique landscape that shapes the future of medicine. What is a Drug Patent?

Drugs 90

Drugs Drug Development Pharmaceuticals Production 90

BioPharma Drive: Drug Pricing

JANUARY 31, 2025

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful biotechs contend with a healthcare system that’s long favored opioids?

Pharmaceuticals 314

Pharmaceuticals Drugs Research 314

Drug Patent Watch

DECEMBER 10, 2024

The pharmaceutical industry has undergone significant changes over the past decade, with a growing trend towards outsourcing key aspects of research, development, and manufacturing to third-party vendors. The Rise of Integrated CDMOs The global biotechnology and pharmaceutical services outsourcing market size was valued at $70.48

Drug Development 83

Drug Development Compliance Pharmaceutical Companies Drugs 83

BioPharma Drive: Drug Pricing

AUGUST 8, 2023

The Indianapolis drugmaker is now worth more than $500 billion, higher than any other pharmaceutical company, as analysts project lucrative markets for its obesity and Alzheimer's drugs.

Marketing 246

Marketing Pharmaceutical Companies Drugs Pharmaceuticals 246

Drug Target Review

JUNE 11, 2025

Drug development is plagued by complex challenges, but multimodal AI is unlocking new opportunities. By integrating diverse data sources – from genomics to clinical insights – this approach is accelerating drug discovery, improving patient stratification and boosting success rates.

Drugs 64

Drugs Clinical Trials Drug Development Pharmaceuticals 64

Drug Patent Watch

MARCH 5, 2025

The Secret Language of Medicines: Uncovering the Science Behind Pharmaceutical Drug Names As professionals in the healthcare and pharmaceutical industries, we've all seen them - the long, complex names of medications that seem to defy pronunciation. What do you think is the most challenging aspect of pharmaceutical drug naming?

Science 82

Science Pharmaceuticals Pharmaceutical Companies Drugs 82

Drug Patent Watch

DECEMBER 3, 2024

In the ever-evolving landscape of pharmaceutical research and development, a revolutionary force is reshaping the way we approach drug discovery and repurposing. This force is none other than Artificial Intelligence (AI) and Machine Learning (ML).

Drugs 87

Drugs Pharmaceuticals Research 87

Drug Patent Watch

DECEMBER 11, 2024

The pharmaceutical industry, particularly the generic drug sector, faces significant challenges in adopting sustainable practices. This article outlines key considerations and strategies for developing a sustainable generic drug development strategy. “Generics are known for their cost-effectiveness.

Drug Development 93

Drug Development Compliance Drugs Pharmaceuticals 93

Drug Patent Watch

NOVEMBER 11, 2024

Effective management of drug patent portfolios is crucial for pharmaceutical companies to maintain market exclusivity, protect revenue streams, and drive innovation. A robust patent strategy aligned with business goals is essential for maximizing value and staying competitive in the pharmaceutical landscape.

Pharmaceutical Companies 100

Pharmaceutical Companies Drugs Pharmaceuticals Marketing 100

Drug Patent Watch

MAY 5, 2025

"As the world grapples with the complexities of global healthcare, one nation is rewriting the rules of the pharmaceutical game: South Africa. From pioneering generic drug production to challenging Big Pharma's dominance, South Africa is redefining what it means to be a leader in the global pharmaceutical landscape.

Pharmaceuticals 81

Pharmaceuticals Production Drugs 81

BioPharma Drive: Drug Pricing

OCTOBER 13, 2023

Acquired with the buyout of Arena Pharmaceuticals, Velsipity enters a competitive market for ulcerative colitis pills.

FDA Approval 286

FDA Approval FDA Pharmaceuticals Marketing 286

Drug Patent Watch

NOVEMBER 26, 2024

In the ever-evolving landscape of pharmaceutical research and development, drug repurposing has emerged as a promising strategy to bring new treatments to patients more quickly and cost-effectively.

Drugs 95

Drugs Pharmaceuticals Treatment Research 95

DrugBaron

FEBRUARY 16, 2024

“There is more than one way to skin a cat” is a rather gruesome British idiom, but its sentiment surely applies to running a successful pharmaceutical portfolio. But not everyone in drug development is playing this game. No wonder investing in drug development is so hard! But how do you know which game you are playing?

Drug Development 355

Drug Development Pharma Companies Drugs Science 355

Drug Patent Watch

DECEMBER 4, 2024

The pharmaceutical industry is undergoing a significant transformation with the advent of machine learning methods. These methods have the potential to revolutionize the drug discovery process by enhancing the efficiency and accuracy of identifying and developing new drug candidates.

Drug Development 89

Drug Development Drugs Pharmaceuticals 89

Drug Patent Watch

DECEMBER 12, 2024

Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand their product portfolio through in-licensing. This approach not only helps maintain market exclusivity but also ensures a steady revenue stream for pharmaceutical companies.

Licensing 83

Licensing Licensing Drugs Pharmaceutical Companies 83

Drug Patent Watch

MAY 14, 2025

"Reviving Old Medicines: How AI-Powered Repurposing is Revolutionizing the Pharmaceutical Industry The pharmaceutical industry is on the cusp of a revolution, driven by the power of computational drug repurposing. From treating cancer to Alzheimer's, the possibilities are endless. link] "

Drugs 80

Drugs Pharmaceuticals Disease Research 80

Drugs.com

MARCH 24, 2025

Food and Drug Administration (FDA) has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra (vutrisiran), is made by Alnylam Pharmaceuticals and is used to. MONDAY, March 24, 2025 -- The U.S.

FDA 279

FDA Pharmaceuticals Drugs 279

Drug Patent Watch

JUNE 17, 2025

"Uncovering Hidden Opportunities: The Secret to Unlocking Pharmaceutical Competitive Intelligence As the pharmaceutical industry continues to evolve, companies are under increasing pressure to stay ahead of the curve. Meet the Orange Book, a treasure trove of data that holds the secrets to pharmaceutical competitive intelligence.

Pharmaceuticals 62

Pharmaceuticals Marketing Drugs 62

BioPharma Drive: Drug Pricing

APRIL 22, 2024

The acquisition of a Nexus Pharmaceuticals facility in Wisconsin could help Lilly better meet demand for injectable medicines, like those it makes for diabetes and obesity.

Pharmaceuticals 278

Pharmaceuticals Drugs 278

PPD

NOVEMBER 11, 2024

It is hard to ignore some of the most pressing, long-term trends driving the push to accelerate innovation and progress in drug development. As a result, biopharma and biotech companies working to bring their drug pipelines to the market require deep expertise from trusted partners to help deliver critical therapies for their patients.

Drug Development 97

Drug Development Clinical Trials Drugs Small Molecule 97

Drug Patent Watch

DECEMBER 8, 2024

The pharmaceutical industry is heavily reliant on patents to protect intellectual property and maintain market exclusivity. However, with the increasing competition from generic and biosimilar manufacturers, patent invalidity claims have become a significant challenge for pharmaceutical companies.

Biosimilars 93

Biosimilars Pharmaceutical Companies Drugs Pharmaceuticals 93

Drug Patent Watch

NOVEMBER 18, 2024

The concept of a blockbuster drug, defined as a medication generating at least $1 billion in annual sales, has long been a cornerstone of the pharmaceutical industry. However, the question arises whether a drug can achieve blockbuster status without heavily relying on U.S.

Drugs 94

Drugs Pharmaceuticals 94

Drug Patent Watch

OCTOBER 30, 2024

The pharmaceutical industry is known for its complex regulatory environment and lengthy product development processes. One often overlooked aspect of this industry is the potential benefits of abandoned and expired patents.

Pharmaceuticals 96

Pharmaceuticals Production Drugs Marketing 96

Drug Patent Watch

JUNE 9, 2025

"Navigating the Maze of Regulations: How Pharmaceutical Companies Can Safeguard Their Drug Portfolios As the pharmaceutical industry continues to evolve, regulatory environments are becoming increasingly complex.

Pharmaceutical Companies 75

Pharmaceutical Companies Drugs Pharmaceuticals Regulations 75

Drug Patent Watch

DECEMBER 11, 2024

This growth has created a competitive landscape where pharmaceutical companies must carefully evaluate and select the right CDMO partner to ensure the success of their projects. Your Drugs Development Stage The stage of your drug development is a critical factor in selecting a CDMO.

Pharmaceutical Companies 94

Pharmaceutical Companies Compliance Pharmaceuticals Drug Development 94

Drug Patent Watch

OCTOBER 1, 2024

The answer often lies in the complex world of drug patents. Let’s dive into the fascinating realm of pharmaceutical intellectual property and explore when drug patents expire. Drug patents are a crucial aspect of the pharmaceutical industry. They provide companies with exclusive… Source

Pharmaceuticals 111

Pharmaceuticals Drugs 111

Drugs.com

JUNE 26, 2023

MONDAY, June 26, 2023 -- After drugmaker Novo Nordisk tweaked its diabetes drug Ozempic into Wegovy — a formulation expressly designed to help users shed pounds — sales of both drugs skyrocketed. Other pharmaceutical giants took notice,

Drugs 214

Drugs Pharmaceuticals 214